id	domain	url
inlawrev-25507	perma.cc	https://perma.cc/34yj-7w79]
inlawrev-25507	perma.cc	https://perma.cc/aj6m-j7zr]
inlawrev-25507	www.i-mak.org	http://www.i-mak.org/wp-content/uploads/2018/10/i-mak-lantus-report-2018-1030f.pdf
inlawrev-25507	perma.cc	https://perma.cc/9xnh-mkbx]
inlawrev-25507	www.i-mak.org	https://www.i-mak.org/wpcontent/uploads/2018/08/imak.100s.patents.totals-2.png
inlawrev-25507	perma.cc	https://perma.cc/62xk-zbep
inlawrev-25507	www.i-mak.org	https://www.i-mak.org/wpcontent/uploads/2018/08/i-mak-overpatented-overpriced-report.pdf
inlawrev-25507	perma.cc	https://perma.cc/9uqfrch8
inlawrev-25507	www.healthaffairs.org	https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2014.1047
inlawrev-25507	perma.cc	https://perma.cc/vza49fa2]
inlawrev-25507	www.investopedia.com	https://www.investopedia.com/terms/b/blockbuster-drug.asp
inlawrev-25507	perma.cc	https://perma.cc/h2tw-hm2x
inlawrev-25507	www.upcounsel.com	https://www.upcounsel.com/how-longdoes-a-drug-patent-last
inlawrev-25507	perma.cc	https://perma.cc/7d5h-wrwx]
inlawrev-25507	www.fda.gov	https://www.fda.gov
inlawrev-25507	perma.cc	https://perma.cc/zpg4-wfgk]
inlawrev-25507	perma.cc	https://perma.cc/nny7-gv4w]
inlawrev-25507	hbr.org	https://hbr.org/2013/11/filing-for-a-patent-versus-keeping-yourinvention-a-trade-secret
inlawrev-25507	perma.cc	https://perma.cc/7db7-9bfs]
inlawrev-25507	www.law.cornell.edu	https://www.law.cornell.edu/wex/patent
inlawrev-25507	perma.cc	https://perma.cc/pe9t-f2ta]
inlawrev-25507	www.nbcnews.com	https://www.nbcnews.com/health/health-news/drugmakers-play-patent-gameward-competitors-n915911
inlawrev-25507	perma.cc	https://perma.cc/l7ft-6f2z
inlawrev-25507	www.wipo.int	https://www.wipo.int/edocs/mdocs/mdocs/en/cdip_15/cdip_15_inf_2.docx
inlawrev-25507	perma.cc	https://perma.cc/wu2m-u3nu]
inlawrev-25507	perma.cc	https://perma.cc/s775-ud87]
inlawrev-25507	www.cnbc.com	https://www.cnbc.com/2018/06/25/high-drug-prices-causedby-us-patent-system.html
inlawrev-25507	perma.cc	https://perma.cc/ux2f-hr62]
inlawrev-25507	www.finnegan.com	https://www.finnegan.com/en/insights/puzzlingout-the-patent-eligibility-of-natural-products.html
inlawrev-25507	perma.cc	https://perma.cc/fh3u-f37d]
inlawrev-25507	www.healthaffairs.org	https://www.healthaffairs.org/doi/pdf/10.1377/hlthaff.2012.0107
inlawrev-25507	news.bloomberglaw.com	https://news.bloomberglaw.com/ip-law/costs-soar-for-tradesecrets-pharma-patent-suits-survey-finds
inlawrev-25507	perma.cc	https://perma.cc/s22x-l2xx]
inlawrev-25507	www.wg-law.com	https://www.wg-law.com/publications/patent-litigation-united-states-overview
inlawrev-25507	perma.cc	https://perma.cc/z3md-9emj]
inlawrev-25507	www.washingtonpost.com	https://www.washingtonpost.com
inlawrev-25507	perma.cc	https://perma.cc/92ht-55rx]
inlawrev-25507	www.reuters.com	https://www.reuters.com/article/us-abbvie-novartish
inlawrev-25507	perma.cc	https://perma.cc/p8nx-h22a]
inlawrev-25507	www.iam-media.com	https://www.iam-media.com/law-policy/why-evergreening-not-dirty-word
inlawrev-25507	www.durbin.senate.gov	https://www.durbin.senate.gov/newsroom/press-releases/durbin-cassidy-introduce-remedy-act-tolow
inlawrev-25507	perma.cc	https://perma.cc/qv7j-fz6t]
inlawrev-25507	www.csrxp.org	https://www.csrxp.org/csrxp-applauds-introduction-ofcassidy-durbin-remedy-act
inlawrev-25507	perma.cc	https://perma.cc/sw65-qcvh]
inlawrev-25507	perma.cc	https://perma.cc/e2hq-ja3r]
inlawrev-25507	www.patentdocs.org	https://www.patentdocs.org/2019/04/more-ill-conceivedremedies-from-congress-regarding-prescription-drug-costs.html
inlawrev-25507	perma.cc	https://perma.cc/4gqq-wqkd]
inlawrev-25507	www.countable.us	https://www.countable.us/bills/s1209-116-reforming-evergreening-and-manipulationthat-extends-drug-years-act
inlawrev-25507	perma.cc	https://perma.cc/67a5-wjf7]
inlawrev-25507	www.cornyn.senate.gov	https://www.cornyn.senate.gov
inlawrev-25507	perma.cc	https://perma.cc/ul77-aklg
inlawrev-25507	www.bigmoleculewatch.com	https://www.bigmoleculewatch.com/2019/05/15/affordable-prescriptions-for-patientsact-introduced-in-the-senate
inlawrev-25507	perma.cc	https://perma.cc/k5fs-pbhs
inlawrev-25507	www.cbo.gov	https://www.cbo.gov/publication/55472
inlawrev-25507	perma.cc	https://perma.cc/np4j-tard]
inlawrev-25507	www.bloomberg.com	https://www.bloomberg.com
inlawrev-25507	perma.cc	https://perma.cc/l4fc-znxs]
inlawrev-25507	perma.cc	https://perma.cc/xl3x-ejnv
inlawrev-25507	www.ipi.org	https://www.ipi.org/ipi_issues/detail/coalition-letter-expressing-concerns-with-s1416-theaffordable-prescriptions-for-patients-act-of-2019
inlawrev-25507	perma.cc	https://perma.cc/l4u9-mavp]
inlawrev-25507	jeffries.house.gov	https://jeffries.house.gov/media-center/press-releases/reps-jeffries-collins-introducebipartisan-legislation-to-lower
inlawrev-25507	perma.cc	https://perma.cc/hy5w-bpcg
inlawrev-25507	www.carlsoncaspers.com	https://www.carlsoncaspers.com/term-act-would-presume-all-patents-covering-a-brandedpharmaceutical-product-are-not-patentably-distinct
inlawrev-25507	perma.cc	https://perma.cc/b6pc-nyyd]
inlawrev-25507	perma.cc	https://perma.cc/tv2d-srcy]
inlawrev-25507	perma.cc	https://perma.cc/964l-5r54
inlawrev-25507	perma.cc	https://perma.cc/r26c-n55x]
inlawrev-25507	perma.cc	https://perma.cc/7rbx-xf8g]
inlawrev-25507	www.fraserinstitute.org	https://www.fraserinstitute.org/sites/default/files/benefits-of-incremental-innovation.pdf
inlawrev-25507	perma.cc	https://perma.cc/7b23-9euh]
inlawrev-25507	cpip.gmu.edu	https://cpip.gmu.edu/2019/06/27/no-combination-drug-patents-act-stalls-but-threats-toinnovation-remain
inlawrev-25507	perma.cc	https://perma.cc/7m39-gcc7]
inlawrev-25507	perma.cc	https://perma.cc/c46l-5ajh]
inlawrev-25507	www.cafc.uscourts.gov	http://www.cafc.uscourts.gov/thecourt/court-jurisdiction
inlawrev-25507	perma.cc	https://perma.cc/4epm-k2fe]
inlawrev-25507	www.cafc.uscourts.gov	http://www.cafc.uscourts.gov/judges/s-jayplager-circuit-judge.html
inlawrev-25507	perma.cc	https://perma.cc/htm5-6rqf
inlawrev-25507	academic.oup.com	https://academic.oup.com/jlb/article/5/3/590/5232981
inlawrev-25507	perma.cc	https://perma.cc/69yh-2sbv]
inlawrev-25507	www.benefitspro.com	https://www.benefitspro.com/2018/10/04
inlawrev-25507	perma.cc	https://perma.cc/7nla-6upq]
inlawrev-25507	www.fda.gov	https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drugproducts-therapeutic-equivalence-evaluations-orange-book
inlawrev-25507	perma.cc	https://perma.cc/9yav-ayqu]
inlawrev-25507	perma.cc	https://perma.cc/9d8r-7xz8]
inlawrev-25507	www.winston.com	https://www.winston.com/en/legal-glossary/bpcia-hatch-waxmanact-differences.html
inlawrev-25507	perma.cc	https://perma.cc/vyr8-2cnh]
inlawrev-25507	www.brinksgilson.com	https://www.brinksgilson.com/state-federal-court-adjudication-federal-patent-issues
inlawrev-25507	perma.cc	https://perma.cc/r4h9-c963]
inlawrev-25507	accessiblemeds.org	https://accessiblemeds.org
inlawrev-25507	perma.cc	https://perma.cc/5ysz-v6pr
inlawrev-25507	perma.cc	https://perma.cc/l6xk-aulk]
inlawrev-25507	www.bloomberg.com	https://www.bloomberg.com/news/articles
inlawrev-25507	perma.cc	https://perma.cc/9sv9lgch
inlawrev-25507	www.ncbi.nlm.nih.gov	https://www.ncbi.nlm.nih.gov/pmc/articles
inlawrev-25507	perma.cc	https://perma.cc/q9ul-df98
inlawrev-25507	www.henrypatentfirm.com	https://www.henrypatentfirm.com/blog/slow-down-patent-prosecution
inlawrev-25507	perma.cc	https://perma.cc/4hhj-h49c
inlawrev-25507	www.healthaffairs.org	https://www.healthaffairs.org/do/10.1377/hblog20170310.059143/full
inlawrev-25507	perma.cc	https://perma.cc/q3du-lrkl]
inlawrev-25507	pharma.nridigital.com	https://pharma.nridigital.com/pharma_nov19/from_
inlawrev-25507	perma.cc	https://perma.cc/l5dg-klgs]
inlawrev-25507	apps.who.int	https://apps.who.int/iris/bitstream/handle/10665/325771/whomvp-emp-iau-2019.06-eng.pdf?ua=1
inlawrev-25507	perma.cc	https://perma.cc/emt4-qjqj
inlawrev-25507	www.hilarispublisher.com	https://www.hilarispublisher.com/open-access/evergreening-inpharmaceuticals-strategies-consequences-and-provisions-for-prevention-in-usa-eu-india-and-othercountries-2167-7689-1000185.pdf
inlawrev-25507	perma.cc	https://perma.cc/ce4h-m3be]
inlawrev-25507	www.fda.gov	https://www.fda.gov/drugs/abbreviated-new-drug-application-anda/hatchwaxman-letters
inlawrev-25507	perma.cc	https://perma.cc/7hnm-nha3]
inlawrev-25507	www.upcounsel.com	https://www.upcounsel.com/orangebook-listed-patents
inlawrev-25507	perma.cc	https://perma.cc/kqz5-ypp2]
inlawrev-25507	www.jpaa.or.jp	https://www.jpaa.or.jp/discoveripjapan/pdf
inlawrev-25507	perma.cc	https://perma.cc/6rlv-a9qy]
inlawrev-25507	www.morganlewis.com	https://www.morganlewis.com/pubs/humira-patentsinvalidated-in-inter-partes-reviews
inlawrev-25507	perma.cc	https://perma.cc/5cdw-nl6x]
inlawrev-25507	www.reuters.com	https://www.reuters.com/article/ip-patent-boehringer/ptab-sides-with-boehringer-inchallenge-to-humira-patent-idusl1n1jy1u8
inlawrev-25507	perma.cc	https://perma.cc/7n5n-qk5f]
inlawrev-25507	www.reuters.com	https://www.reuters.com/article/ip-patent-humira-idusl1n29d008
inlawrev-25507	perma.cc	https://perma.cc/u9rb-5nzq]
inlawrev-25507	www.future-science.com	https://www.future-science.com/doi/full/10.4155/ppa-2017-0012
inlawrev-25507	perma.cc	https://perma.cc/6mdh-c3hm]
inlawrev-25507	www.biospace.com	https://www.biospace.com/article/fda-approves-humira-biosimilar-thatwon-t-be-available-until-2023
inlawrev-25507	perma.cc	https://perma.cc/2ejj-hz5h]
inlawrev-25507	www.goodrx.com	www.goodrx.com/blog/new-biosimilar-approved-for-humira
inlawrev-25507	perma.cc	https://perma.cc/4sj5-mfvm]
inlawrev-25507	www.gabionline.net	http://www.gabionline.net/biosimilars/news/fda-approves-adalimumabbiosimilar-hadlima
inlawrev-25507	perma.cc	https://perma.cc/hjq6-ns2j]
inlawrev-25507	www.chicagobusiness.com	https://www.chicagobusiness.com/joe-cahill-business/humira-patent-strategy-makescase-reform
inlawrev-25507	perma.cc	https://perma.cc/yp98-kbk3]
inlawrev-25507	www.markmanadvisors.com	https://www.markmanadvisors.com/blog/2018/8/27/didabbvie-create-a-wrongful-patent-thicket-around-humira
inlawrev-25507	perma.cc	https://perma.cc/jfc7-ux8q]
inlawrev-25507	biopharmapatent.blogspot.com	http://biopharmapatent.blogspot.com/2016/09/abbvies-humira-patent-portfolio.html
inlawrev-25507	www.ncbi.nlm.nih.gov	https://www.ncbi.nlm.nih.gov/pubmed/17017952
inlawrev-25507	perma.cc	https://perma.cc
inlawrev-25507	www.acsh.org	https://www.acsh.org/news/2019/08/07/how-bigpharma-uses-logically-impossible-patents-block-innovation-14207
inlawrev-25507	perma.cc	https://perma.cc/ara9-kzje]
inlawrev-25507	patentlyo.com	https://patentlyo.com/media/2017/11/usptopatent-prosecution-research-data_unlocking-office-action-traits-1.pdf
inlawrev-25507	perma.cc	https://perma.cc/nwh8u33l
inlawrev-25507	www.usatoday.com	https://www.usatoday.com/story/opinion/2019/07/18/big-pharma-playsgames-drug-patents-you-pay-editorials-debates/1769746001
inlawrev-25507	perma.cc	https://perma.cc/p4zr-qudc]
inlawrev-25507	www.washingtonexaminer.com	https://www.washingtonexaminer.com/senators-want-toclamp-down-on-drugmakers-patent-protections
inlawrev-25507	perma.cc	https://perma.cc/ds96-cfxg]